Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
If you have been following health news lately, you have probably heard about GLP-1 medications, which are prescription treatments that may be used as part of medical weight management for suitable individuals
For patients exploring whether the branded version is worth the premium over alternatives, the comparison of GLP-1 medications and Ozempic provides useful context
Ro exited compounded GLP-1s in 2026 amid FDA enforcement pressure on the category Brand-name Wegovy oral pill (FDA-approved semaglutide) $149/month first month, rising to $199$299/month at higher ongoing doses Brand-name Wegovy injection/pen (FDA-approved) $199/month first month, rising to $199$399/month ongoing Brand-name Zepbound KwikPen (FDA-approved tirzepatide) $299/month first month, rising to $399$449/month ongoing Brand-name Ozempic (FDA-approved semaglutide for type 2 diabetes) insurance-dependent pricing (not independently verified this sweep) Important compliance note on compounded products Compounded semaglutide and compounded tirzepatide whether obtained through Cora Health or other telehealth platforms that offer compounded medication are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound)
This does not constitute medical advice
Each consultation reinforces the importance of urgency and progress
If left untreated, they may progress to coma and death
